NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Clinical trial NCT04136184 · COMPLETED
Trial details
- NCT number
- NCT04136184
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2023-04-11
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.